Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins

OHSS · ovulation induction in polycystic ovarian syndrome

It is very uncertain whether recombinant follicle stimulating hormone changes incidence of OHSS per woman compared with urinary‐derived gonadotrophins (very low certainty).

1 finding from 1 review

Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes only
RR 1.48 [0.82, 2.65]
10 studies · 1565 participants
Very low

Recombinant luteinizing hormone (rLH) combined with recombinant follicle‐stimulating hormone (rFSH) vs rFSH alone

OHSS · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures

Recombinant luteinizing hormone (rLH) combined with recombinant… showed no clear difference in OHSS incidence compared with rFSH alone (low certainty).

1 finding from 1 review

Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in… 2017 · Cochrane Headline outcomes only
OR 0.38 [0.14, 1.01]
6 studies · 2178 participants
Low